Rhode Island Benefiting from Pfizer Settlement
Providence-AP) -- Rhode Island will receive 25-thousand dollars as part of a nationwide settlement with Warner-Lambert, a subsidiary of pharmaceutical giant Pfizer, Incorporated. The settlement resolves claims about deceptive marketing of the prescription drug Neurontin.
Warner-Lambert agreed to pay a total of 38 million dollars. At issue are claims that Warner-Lambert violated state consumer protection laws by aggressively promoting the epilepsy drug Neurontin for so-called "off label uses." The uses were not tested and approved by the U-S Food and Drug Administration.
It is illegal for pharmaceutical manufacturers to promote off-label use of their drugs, although doctors may prescribe them for such uses. The attorney general's office announced the settlement today.
|
